> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CBER Planning 14 Guidances This Year
- URL: https://www.fdaweb.com/cber-planning-14-guidances-this-year/
- Published: 2017-01-19T12:00:00.000Z
- Updated: 2026-09-14T22:01:25.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5137768

CBER says it is considering developing 14 guidances in three categories during calendar year 2017\. The [list](http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/UCM431409.pdf?ref=fdaweb.com) includes topics that currently have no guidance associated with them, topics where updated guidance may be helpful, and topics for which CBER has already issued Level 1 drafts that may be finalized following review of public comments.

The agenda shows seven guidances for blood and blood components, six for tissues and advanced therapies, and one in the “other” category.